title: The Promotion of Medical Products in the 21st Century: Off-label Marketing and First Amendment Concerns.
authors.affiliation: Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
authors.forename: Joshua M
authors.initials: JM
authors.lastname: Sharfstein
authors.affiliation: University of Wisconsin Law School and School of Medicine & Public Health, Madison.
authors.forename: Alta
authors.initials: A
authors.lastname: Charo
mesh_terms: D000329:Advertising; D004345:Drug Industry; D015118:Eicosapentaenoic Acid / Q000031:analogs & derivatives; D000960:Hypolipidemic Agents; D007878:Legislation as Topic; D007880:Legislation, Drug; D056687:Off-Label Use / Q000331:legislation & jurisprudence*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000960:Hypolipidemic Agents; C035276:eicosapentaenoic acid ethyl ester; D015118:Eicosapentaenoic Acid